Neurological Complications of Immunotherapy
- To describe type and pattern of neurotoxicity encountered in patients treated with checkpoint inhibitors and CAR-T cells
- To define potential biomarkers of immunotherapy associated neurotoxicity
- To discuss management considerations of patients with immunotherapy
Jorg Dietrich, MD, PhD
Harvard Medical School
Please fill out the webform at the time of enrollment. *See step 2 in the instructions.
Instructions on How to Watch the Module:
- Click the Take Course Button
- On the course progress bar, click the webform.
- Click the blue start button to fill out the webform.
- Complete the webform, then click submit.
- Then Click next to proceed to the video
If you have any technical difficulties or have any questions, please reach out to email@example.com.